Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Evaluation of a Standardized Geriatric Assessment at Diagnosis in a Prospective Cohort of Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia

Colombe Saillard, MD, Frederique Rousseau, Maud Cecile, Cecile Braticevic, Anne Etienne, Jerome Rey, Evelyne D'Incan, Christophe Zemmour, Norbert Vey, MD PhD, Aude Charbonnier

Blood (2018) 132 (Supplement 1): 2671.

https://doi.org/10.1182/blood-2018-99-116400

Published: 2018

Journal Articles

Preventive Versus Curative Platelet Transfusion Strategies in the Treatment of Acute Myeloid Leukemia Patients: A Comparative Study

Aude Charbonnier, MD PhD, Michel Raba, MD, Patrick Ladaique, Laurence Augey, MD, Lilian Laborde, Jeremy Monfray, CRA, Carine Champigneulle, CRA, Mohamad Sobh, Pharm.M., Helene Labussiere-Wallet, MD, Fiorenza Barraco, MD, Sophie Ducastelle, MD, Xavier Thomas, MD PhD, Anne Etienne, MD, Thomas Prebet, MD PhD, Evelyne D'Incan, MD, Jerome Rey, MD, Franck E. Nicolini, MD PhD, Norbert Vey, MD, Mauricette Michallet, MD PhD

Blood (2014) 124 (21): 4288.

https://doi.org/10.1182/blood.V124.21.4288.4288

Published: 2014

Journal Articles

Chemoimmunotherapy Combining Vincristine, Dexamethasone and Epratuzumab (hLL2) As Salvage Regimen for Older Relapsed/Refractory, CD22 + B-Acute Lymphoblastic Leukemia (B-ALL) Patients: Results of the French Non-Intensive Phase 2 Prospective Cheprall Study

Patrice Chevallier, Françoise Huguet, Emmanuel Raffoux, MD, Anne Etienne, MD, Thibaut Leguay, MD, Françoise Isnard, MD, Nelly Robillard, Thierry Guillaume, MD, Jacques Delaunay, MD, Pierre Peterlin, MD, Aude Charbonnier, MD, Arnaud Pigneux, MD PhD, Claire Le Houerou, David M Goldenberg, ScD, MD, William A Wegener, MD PhD, Hervé Dombret, MD PhD

Blood (2014) 124 (21): 3710.

https://doi.org/10.1182/blood.V124.21.3710.3710

Published: 2014

Journal Articles

Early ICU Admission Of Newly Diagnosed Acute Myeloid Leukemia With No Organ Failure

Elodie Elkaim, Djamel Mokart, MD, PhD, Norbert Vey, MD PhD, Aude Charbonnier, MD, PhD, Evelyne D’Incan, M.D., Jerome Rey, MD, Thomas Prebet, MD, PhD, Jean-Paul Brun, MD, Antoine Sannini, MD, Muriel Picard, Christian Recher, MD PhD, Anne Etienne, MD

Blood (2013) 122 (21): 3896.

https://doi.org/10.1182/blood.V122.21.3896.3896

Published: 2013

Journal Articles

Impact Of Anthracycline Dose Intensification On Minimal Residual Disease and Outcome Of Core Binding Factors Acute Myeloid Leukemias

Thomas Prebet, MD, PhD, Sarah Bertoli, Eric Delabesse, MD, PhD, Marie-Joelle Mozziconacci, MD, Anne Etienne, MD, Christian Recher, MD PhD, Françoise Huguet, Norbert Vey, MD

Blood (2013) 122 (21): 2681.

https://doi.org/10.1182/blood.V122.21.2681.2681

Published: 2013

Journal Articles

Repeated Dosing Of Anti-KIR (IPH2101) As Maintenance Therapy In Ederly Patients With Acute Myeloid Leukemia

Norbert Vey, MD, Jean-Henri Bourhis, MD, PhD, Christian Recher, MD PhD, Anne Etienne, MD, Aude Charbonnier, MD, PhD, Pascale Andre, PhD, Jérôme Rey, MD, Franceline Calmels, Robert Zerbib, Renaud Buffet, MD, Thomas Prebet, MD, PhD

Blood (2013) 122 (21): 2696.

https://doi.org/10.1182/blood.V122.21.2696.2696

Published: 2013

Journal Articles

A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission

Norbert Vey, Jean-Henri Bourhis, Nicolas Boissel, Dominique Bordessoule, Thomas Prebet, Aude Charbonnier, Anne Etienne, Pascale Andre, François Romagne, Don Benson, Herve Dombret, Daniel Olive

Blood (2012) 120 (22): 4317–4323.

https://doi.org/10.1182/blood-2012-06-437558

Published: 2012

Includes: Supplemental data

Journal Articles

Post-Transplant Outcome in Patients with Acute Myeloid Leukemia and Myelodysplasic Syndrome Who Received Conditioning Regimen Based On Fludarabin, Busulfan and Anti-Thymoglobulin Prior to Allogeneic Hematopoietic Stem Cell Transplantation

Claire Oudin, MD, Patrice Chevallier, MD, PhD, Sabine Furst, MD, Thierry Guillaume, MD, Jean El Cheikh, MD, Roberto Crocchiolo, MD, Jacques Delaunay, MD, Anne Etienne, MD, Norbert Vey, MD, PhD, Mohamad Mohty, MD PhD, Didier Blaise, MD

Blood (2012) 120 (21): 2013.

https://doi.org/10.1182/blood.V120.21.2013.2013

Published: 2012

Journal Articles

Trastuzumab for treatment of refractory/relapsed HER2-positive adult B-ALL: results of a phase 2 GRAALL study

Patrice Chevallier, Nelly Robillard, Aude Charbonnier, Emmanuel Raffoux, Sebastien Maury, Sylvain Carras, Cecile Chabrot, Cecile Fohrer, Marc Bernard, Jean-Sebastien Blade, Anne Etienne, Pascaline Talmant, Jacques Delaunay, Thierry Guillaume, Mohamad Mohty, Marie-Christine Bene, Norbert Ifrah, Herve Dombret

Blood (2012) 119 (11): 2474–2477.

https://doi.org/10.1182/blood-2011-11-390781

Published: 2012

Journal Articles

Combination of Cytarabine and Topotecan Improves Response Rate for Patients Treated for Acute Myeloid Leukemia with Persistent Disease After Frontline Induction

Thomas Prebet, MD, PhD, Estelle Jean, M.D., Aurelie Autret, B.Sc., Aude Charbonnier, Jerome Rey, MD, Anne Etienne, MD, Evelyne D'Incan, M.D., Sabine Furst, MD, Christine Arnoulet, Pharm. D., Didier Blaise, MD, Norbert Vey, MD

Blood (2011) 118 (21): 2605.

https://doi.org/10.1182/blood.V118.21.2605.2605

Published: 2011

Journal Articles

Trastuzumab (Herceptin®) for Treatment of Refractory/Relapsed HER2 Positive Adult B-ALL: Results of a Phase II GRAALL Study

Patrice Chevallier, MD, Nelly Robillard, Aude Charbonnier, Emmanuel Raffoux, MD, PhD, Sébastien Maury, Sylvain Carras, Cecile Chabrot, Cecile Fohrer, Marc Bernard, Jean-Sebastien Blade, Anne Etienne, MD, Pascaline Talmant, Jacques Delaunay, Thierry Guillaume, Mohamad Mohty, Norbert Ifrah, Herve Dombret

Blood (2011) 118 (21): 1525.

https://doi.org/10.1182/blood.V118.21.1525.1525

Published: 2011

Journal Articles

Outcome of Relapse After Allogeneic Stem Cell Transplantation (SCT) In Patients with acute Myeloid Leukaemia (AML).

Raynier Devillier, Roberto Crocchiolo, Jr, Anne Etienne, MD, Thomas Prebet, M.D., Ph.D., Aude Charbonnier, Sabine Furst, Jean El Cheikh, Evelyne D’Incan, Jerome Rey, Catherine Faucher, Didier Blaise, MD, Norbert Vey, MD

Blood (2010) 116 (21): 4514.

https://doi.org/10.1182/blood.V116.21.4514.4514

Published: 2010

Journal Articles

A Direct Comparison of High Dose Cytarabine to Combination of Gemtuzumab and High Dose Cytarabine for Acute Myeloid Leukemia Patients in First Relapse Confirmed the Benefit of Gemtuzumab Based Regimens.

Thomas Prébet, MD, Aude Charbonnier, MD, PhD, Anne Etienne, MD, Evelyne D'Incan, MD, Sabine Fürst, MD, Didier Blaise, MD, Norbert Vey, MD

Blood (2009) 114 (22): 2051.

https://doi.org/10.1182/blood.V114.22.2051.2051

Published: 2009

Journal Articles

Analysis of NK Cells Receptors and NK Cells Ligands in Acute Myeloid Leukemia: Comparisons Between the Blood and the Bone Marrow.

Jerome Rey, Eloise Perrot, Caroline Veuillen, Thomas Prébet, MD, Anne Etienne, Aude Charbonnier, Evelyne D'Incan, Norbert Vey, Daniel Olive, MD, PhD

Blood (2009) 114 (22): 1643.

https://doi.org/10.1182/blood.V114.22.1643.1643

Published: 2009

Journal Articles

Impact of CRi on the Outcome of Elderly Patients with Untreated Acute Myeloid Leukemia (AML)

Anne Etienne, Aude Charbonnier, Thomas Prebet, Diane Coso, Evelyne D’Incan, Marie-Francoise Doglio, Daniele Sainty, Marie-Joelle Mozziconacci, Jerome Rey, Norbert Vey

Blood (2008) 112 (11): 2988.

https://doi.org/10.1182/blood.V112.11.2988.2988

Published: 2008

Journal Articles

Prognostic Impact of Mutations in the Nucleophosmin ( NPM1 ) and of the FMS-Related Tyrosine Kinase 3 ( FLT3 ) Genes in Elderly Patients with Acute Myeloid Leukemia (AML) Treated with Intensive Chemotherapy

Anne Etienne, Cecile Borel, Sarah Reutenauer, Sylviane Olschwang, Marie-Joelle Mozziconacci, Eric Delabesse, Cecile Demur, Thomas Prebet, Francoise Huguet, Aude Charbonnier, Christian Recher, Norbert Vey

Blood (2008) 112 (11): 2542.

https://doi.org/10.1182/blood.V112.11.2542.2542

Published: 2008

Journal Articles

Decision Criteria for the Futility of Intensive Chemotherapy in Older Patients with Acute Myeloid Leukemia (AML).

Hervé Dombret, Jean-Valère Malfuson, Anne Etienne, Pascal Turlure, Thierry de Revel, Xavier Thomas, Nathalie Contentin, Christine Terré, Mauricette Michallet, Sylvie Castaigne, Dominique Bordessoule, Norbert Vey, Claude Gardin

Blood (2007) 110 (11): 2861.

https://doi.org/10.1182/blood.V110.11.2861.2861

Published: 2007

Journal Articles

Impact of CRi on the Outcome of Elderly Patients with Acute Myeloid Leukemia.

Anne Etienne, Aude Charbonnier, Thomas Prebet, Diane Coso, Anne-Marie Stoppa, Evelyne D’Incan, Marie-Françoise Doglio, Danièle Sainty, Marie-Joelle Mozziconacci, Jérome Rey, Jean-Albert Gastaut, Norbert Vey

Blood (2007) 110 (11): 4384.

https://doi.org/10.1182/blood.V110.11.4384.4384

Published: 2007

Journal Articles

High Relapse Rate of Acute Myeloid Leukemia with Translocation (8;21) or Inversion (16) in Elderly Patients Treated with Conventional Chemotherapy.

Thomas Prebet, MD, Fanny Bernard, MD, Anne Etienne, MD, Aude Charbonnier, MD, PhD, Marie Joelle Mozziconacci, MD, Diane Coso, MD, Anne-Marie Stoppa, MD, Danièle Sainty, MD, Jean Albert Gastaud, MD, Norbert Vey, MD

Blood (2007) 110 (11): 4365.

https://doi.org/10.1182/blood.V110.11.4365.4365

Published: 2007

Journal Articles

Long Term Infectious Complications Following Reduced Intensity Conditioning (RIC) Allogeneic HLA-Identical Sibling Transplantation (allo-SCT).

Anne Etienne, MD, Mohamad Mohty, MD, PhD, Catherine Faucher, MD, Sabine Furst, MD, Jean El-Cheikh, MD, Christine Zandotti, MD, Pierre Berger, MD, Norbert Vey, MD, Anne-Marie Stoppa, MD, Reda Bouabdallah, MD, Patrice Viens, MD, Jean-Albert Gastaut, MD, Didier Blaise, MD

Blood (2006) 108 (11): 2850.

https://doi.org/10.1182/blood.V108.11.2850.2850

Published: 2006

NARROW

Evaluation of a Standardized Geriatric Assessment at Diagnosis in a Prospective Cohort of Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia

Preventive Versus Curative Platelet Transfusion Strategies in the Treatment of Acute Myeloid Leukemia Patients: A Comparative Study

Chemoimmunotherapy Combining Vincristine, Dexamethasone and Epratuzumab (hLL2) As Salvage Regimen for Older Relapsed/Refractory, CD22 + B-Acute Lymphoblastic Leukemia (B-ALL) Patients: Results of the French Non-Intensive Phase 2 Prospective Cheprall Study

Early ICU Admission Of Newly Diagnosed Acute Myeloid Leukemia With No Organ Failure

Impact Of Anthracycline Dose Intensification On Minimal Residual Disease and Outcome Of Core Binding Factors Acute Myeloid Leukemias

Repeated Dosing Of Anti-KIR (IPH2101) As Maintenance Therapy In Ederly Patients With Acute Myeloid Leukemia

A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission

Post-Transplant Outcome in Patients with Acute Myeloid Leukemia and Myelodysplasic Syndrome Who Received Conditioning Regimen Based On Fludarabin, Busulfan and Anti-Thymoglobulin Prior to Allogeneic Hematopoietic Stem Cell Transplantation

Trastuzumab for treatment of refractory/relapsed HER2-positive adult B-ALL: results of a phase 2 GRAALL study

Combination of Cytarabine and Topotecan Improves Response Rate for Patients Treated for Acute Myeloid Leukemia with Persistent Disease After Frontline Induction

Trastuzumab (Herceptin®) for Treatment of Refractory/Relapsed HER2 Positive Adult B-ALL: Results of a Phase II GRAALL Study

Outcome of Relapse After Allogeneic Stem Cell Transplantation (SCT) In Patients with acute Myeloid Leukaemia (AML).

A Direct Comparison of High Dose Cytarabine to Combination of Gemtuzumab and High Dose Cytarabine for Acute Myeloid Leukemia Patients in First Relapse Confirmed the Benefit of Gemtuzumab Based Regimens.

Analysis of NK Cells Receptors and NK Cells Ligands in Acute Myeloid Leukemia: Comparisons Between the Blood and the Bone Marrow.

Impact of CRi on the Outcome of Elderly Patients with Untreated Acute Myeloid Leukemia (AML)

Prognostic Impact of Mutations in the Nucleophosmin ( NPM1 ) and of the FMS-Related Tyrosine Kinase 3 ( FLT3 ) Genes in Elderly Patients with Acute Myeloid Leukemia (AML) Treated with Intensive Chemotherapy

Decision Criteria for the Futility of Intensive Chemotherapy in Older Patients with Acute Myeloid Leukemia (AML).

Impact of CRi on the Outcome of Elderly Patients with Acute Myeloid Leukemia.

High Relapse Rate of Acute Myeloid Leukemia with Translocation (8;21) or Inversion (16) in Elderly Patients Treated with Conventional Chemotherapy.

Long Term Infectious Complications Following Reduced Intensity Conditioning (RIC) Allogeneic HLA-Identical Sibling Transplantation (allo-SCT).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only